Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anxiety Disorder Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Itriglumide
1.2.3 Tedatioxetine
1.2.4 EDG-004
1.2.5 Others
1.3 Market by Application
1.3.1 Global General Anxiety Disorder Therapeutics Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anxiety Disorder Therapeutics Market Perspective (2018-2034)
2.2 General Anxiety Disorder Therapeutics Growth Trends by Region
2.2.1 Global General Anxiety Disorder Therapeutics Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 General Anxiety Disorder Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 General Anxiety Disorder Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 General Anxiety Disorder Therapeutics Market Dynamics
2.3.1 General Anxiety Disorder Therapeutics Industry Trends
2.3.2 General Anxiety Disorder Therapeutics Market Drivers
2.3.3 General Anxiety Disorder Therapeutics Market Challenges
2.3.4 General Anxiety Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anxiety Disorder Therapeutics Players by Revenue
3.1.1 Global Top General Anxiety Disorder Therapeutics Players by Revenue (2018-2024)
3.1.2 Global General Anxiety Disorder Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global General Anxiety Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anxiety Disorder Therapeutics Revenue
3.4 Global General Anxiety Disorder Therapeutics Market Concentration Ratio
3.4.1 Global General Anxiety Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anxiety Disorder Therapeutics Revenue in 2022
3.5 General Anxiety Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players General Anxiety Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into General Anxiety Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anxiety Disorder Therapeutics Breakdown Data by Type
4.1 Global General Anxiety Disorder Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global General Anxiety Disorder Therapeutics Forecasted Market Size by Type (2024-2034)
5 General Anxiety Disorder Therapeutics Breakdown Data by Application
5.1 Global General Anxiety Disorder Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global General Anxiety Disorder Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America General Anxiety Disorder Therapeutics Market Size (2018-2034)
6.2 North America General Anxiety Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America General Anxiety Disorder Therapeutics Market Size by Country (2018-2024)
6.4 North America General Anxiety Disorder Therapeutics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anxiety Disorder Therapeutics Market Size (2018-2034)
7.2 Europe General Anxiety Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe General Anxiety Disorder Therapeutics Market Size by Country (2018-2024)
7.4 Europe General Anxiety Disorder Therapeutics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anxiety Disorder Therapeutics Market Size (2018-2034)
8.2 Asia-Pacific General Anxiety Disorder Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific General Anxiety Disorder Therapeutics Market Size by Region (2018-2024)
8.4 Asia-Pacific General Anxiety Disorder Therapeutics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anxiety Disorder Therapeutics Market Size (2018-2034)
9.2 Latin America General Anxiety Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America General Anxiety Disorder Therapeutics Market Size by Country (2018-2024)
9.4 Latin America General Anxiety Disorder Therapeutics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anxiety Disorder Therapeutics Market Size (2018-2034)
10.2 Middle East & Africa General Anxiety Disorder Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa General Anxiety Disorder Therapeutics Market Size by Country (2018-2024)
10.4 Middle East & Africa General Anxiety Disorder Therapeutics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bionomics Limited
11.1.1 Bionomics Limited Company Detail
11.1.2 Bionomics Limited Business Overview
11.1.3 Bionomics Limited General Anxiety Disorder Therapeutics Introduction
11.1.4 Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2018-2024)
11.1.5 Bionomics Limited Recent Development
11.2 Edgemont Pharmaceuticals, LLC
11.2.1 Edgemont Pharmaceuticals, LLC Company Detail
11.2.2 Edgemont Pharmaceuticals, LLC Business Overview
11.2.3 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Introduction
11.2.4 Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2018-2024)
11.2.5 Edgemont Pharmaceuticals, LLC Recent Development
11.3 H. Lundbeck A/S
11.3.1 H. Lundbeck A/S Company Detail
11.3.2 H. Lundbeck A/S Business Overview
11.3.3 H. Lundbeck A/S General Anxiety Disorder Therapeutics Introduction
11.3.4 H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2018-2024)
11.3.5 H. Lundbeck A/S Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global General Anxiety Disorder Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Itriglumide
Table 3. Key Players of Tedatioxetine
Table 4. Key Players of EDG-004
Table 5. Key Players of Others
Table 6. Global General Anxiety Disorder Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global General Anxiety Disorder Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global General Anxiety Disorder Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global General Anxiety Disorder Therapeutics Market Share by Region (2018-2024)
Table 10. Global General Anxiety Disorder Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global General Anxiety Disorder Therapeutics Market Share by Region (2024-2034)
Table 12. General Anxiety Disorder Therapeutics Market Trends
Table 13. General Anxiety Disorder Therapeutics Market Drivers
Table 14. General Anxiety Disorder Therapeutics Market Challenges
Table 15. General Anxiety Disorder Therapeutics Market Restraints
Table 16. Global General Anxiety Disorder Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global General Anxiety Disorder Therapeutics Market Share by Players (2018-2024)
Table 18. Global Top General Anxiety Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anxiety Disorder Therapeutics as of 2022)
Table 19. Ranking of Global Top General Anxiety Disorder Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by General Anxiety Disorder Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players General Anxiety Disorder Therapeutics Product Solution and Service
Table 23. Date of Enter into General Anxiety Disorder Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global General Anxiety Disorder Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global General Anxiety Disorder Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global General Anxiety Disorder Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global General Anxiety Disorder Therapeutics Revenue Market Share by Type (2024-2034)
Table 29. Global General Anxiety Disorder Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global General Anxiety Disorder Therapeutics Revenue Market Share by Application (2018-2024)
Table 31. Global General Anxiety Disorder Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global General Anxiety Disorder Therapeutics Revenue Market Share by Application (2024-2034)
Table 33. North America General Anxiety Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America General Anxiety Disorder Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America General Anxiety Disorder Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe General Anxiety Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. Europe General Anxiety Disorder Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe General Anxiety Disorder Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific General Anxiety Disorder Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Asia-Pacific General Anxiety Disorder Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific General Anxiety Disorder Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America General Anxiety Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Latin America General Anxiety Disorder Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America General Anxiety Disorder Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa General Anxiety Disorder Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 46. Middle East & Africa General Anxiety Disorder Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa General Anxiety Disorder Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 48. Bionomics Limited Company Detail
Table 49. Bionomics Limited Business Overview
Table 50. Bionomics Limited General Anxiety Disorder Therapeutics Product
Table 51. Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2018-2024) & (US$ Million)
Table 52. Bionomics Limited Recent Development
Table 53. Edgemont Pharmaceuticals, LLC Company Detail
Table 54. Edgemont Pharmaceuticals, LLC Business Overview
Table 55. Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Product
Table 56. Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2018-2024) & (US$ Million)
Table 57. Edgemont Pharmaceuticals, LLC Recent Development
Table 58. H. Lundbeck A/S Company Detail
Table 59. H. Lundbeck A/S Business Overview
Table 60. H. Lundbeck A/S General Anxiety Disorder Therapeutics Product
Table 61. H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2018-2024) & (US$ Million)
Table 62. H. Lundbeck A/S Recent Development
Table 63. Research Programs/Design for This Report
Table 64. Key Data Information from Secondary Sources
Table 65. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Anxiety Disorder Therapeutics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global General Anxiety Disorder Therapeutics Market Share by Type: 2022 VS 2034
Figure 3. Itriglumide Features
Figure 4. Tedatioxetine Features
Figure 5. EDG-004 Features
Figure 6. Others Features
Figure 7. Global General Anxiety Disorder Therapeutics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global General Anxiety Disorder Therapeutics Market Share by Application: 2022 VS 2034
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. General Anxiety Disorder Therapeutics Report Years Considered
Figure 13. Global General Anxiety Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global General Anxiety Disorder Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global General Anxiety Disorder Therapeutics Market Share by Region: 2022 VS 2034
Figure 16. Global General Anxiety Disorder Therapeutics Market Share by Players in 2022
Figure 17. Global Top General Anxiety Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anxiety Disorder Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by General Anxiety Disorder Therapeutics Revenue in 2022
Figure 19. North America General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America General Anxiety Disorder Therapeutics Market Share by Country (2018-2034)
Figure 21. United States General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe General Anxiety Disorder Therapeutics Market Share by Country (2018-2034)
Figure 25. Germany General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific General Anxiety Disorder Therapeutics Market Share by Region (2018-2034)
Figure 33. China General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America General Anxiety Disorder Therapeutics Market Share by Country (2018-2034)
Figure 41. Mexico General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa General Anxiety Disorder Therapeutics Market Share by Country (2018-2034)
Figure 45. Turkey General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia General Anxiety Disorder Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Bionomics Limited Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2018-2024)
Figure 48. Edgemont Pharmaceuticals, LLC Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2018-2024)
Figure 49. H. Lundbeck A/S Revenue Growth Rate in General Anxiety Disorder Therapeutics Business (2018-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed